Fresolimumab |
Catalog No.GC65539 |
Le fresolimumab (GC1008) est un anticorps monoclonal entièrement humain de haute affinité qui neutralise la forme active des TGFβ1, TGFβ2 et TGFβ3 humains.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 948564-73-6
Sample solution is provided at 25 µL, 10mM.
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases [1].
[1]. Morris JC, et al. Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One. 2014;9(3):e90353. Published 2014 Mar 11.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *